Supported by an expansive portfolio of device IP, we’ve led the field. Bolstered by predictive engineering and rapid prototyping capabilities, we strive to be on the cutting edge of novel inhalation device development. Our to-date developments include: metered-dose inhalers (MDIs), nasal MDIs, dry-powder inhalers (DPIs), soft-mist inhalers (SMIs), digital/connected devices, nebulizers, components (canisters, valves, dose counters), and application of novel coatings. We also have experience with tech transfers. Whatever your need, Kindeva has you covered.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
